Italy vs Malta: Reported rate of new cervical cancer cases
Italy
4.9 per 100,000 women
in 2017
Malta
2.23 per 100,000 women
in 2017
Italy rank
42nd
Malta rank
45th
Reported rate of new cervical cancer cases over time
- Italy
- Malta
How they compare
Italy currently reports 4.9 per 100,000 women against 2.23 per 100,000 women in Malta, a difference of 2.67 per 100,000 women.
That makes Italy's figure about 2.2 times Malta's.
The two have swapped places 8 times across 15 shared years of data; in 2003 it was Italy ahead.
Italy ranks 42nd and Malta ranks 45th of 46 countries.
Italy has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Italy | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.25 per 100,000 women | 3.85 per 100,000 women | 1.4 per 100,000 women | Italy |
| 2010s | 4.54 per 100,000 women | 3.97 per 100,000 women | 0.5652 per 100,000 women | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Italy or Malta?
- Italy, at 4.9 per 100,000 women against 2.23 per 100,000 women in Malta as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Italy and Malta?
- 2.67 per 100,000 women, with Italy ahead.
- How many years of comparable data are there for Italy and Malta?
- 15 years are reported by both, from 2003 to 2017.
- How do Italy and Malta rank globally for reported rate of new cervical cancer cases?
- Italy ranks 42nd and Malta ranks 45th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.